Sad that my first thought is to question if something underhand is happening.
Of the feedback to NICE I have seen, that basically supporting the rejection of the current BPS approach and even arguing for more radical change than in the draft, particularly from patient groups, was so much fuller, better prepared and better argued than the little I have seen from the BPS proponents. Given the stakeholder representations will be published in full, hopefully any intelligent reader will see that too. However obviously the pro BPS stakeholders have not shared as much as the patient organisations.
As others have said, NICE should have been fully aware of the volume of comments by the start of January, so why wait so long to delay publication at the last minute? Are the full Committee still meeting to address the comments submitted and to agree any amendments to the draft, are there now new meetings being booked in after the cancelled April publication date? What input/control does the Committee have over any subsequent alterations to the draft or can NICE unilaterally rewrite the guidelines?
The potential knock on ramifications for the new guidelines if they continue in line with the published draft are potentially enormous and extend both beyond the UK and beyond the ME/CFS world. Potentially they impact on more than ME/CFS specialist services but also MUS, IAPT and the ever expanding CBT empire building and future Long Covid service provision. So it is likely there are lots of health politics cogs turning behind the scenes. How do we gain any insight into what is happening now?